Literature DB >> 26624825

Relationship Between Cesarean Delivery Rate and Maternal and Neonatal Mortality.

George Molina1, Thomas G Weiser2, Stuart R Lipsitz3, Micaela M Esquivel2, Tarsicio Uribe-Leitz2, Tej Azad4, Neel Shah5, Katherine Semrau6, William R Berry6, Atul A Gawande6, Alex B Haynes1.   

Abstract

IMPORTANCE: Based on older analyses, the World Health Organization (WHO) recommends that cesarean delivery rates should not exceed 10 to 15 per 100 live births to optimize maternal and neonatal outcomes.
OBJECTIVES: To estimate the contemporary relationship between national levels of cesarean delivery and maternal and neonatal mortality. DESIGN, SETTING, AND PARTICIPANTS: Cross-sectional, ecological study estimating annual cesarean delivery rates from data collected during 2005 to 2012 for all 194 WHO member states. The year of analysis was 2012. Cesarean delivery rates were available for 54 countries for 2012. For the 118 countries for which 2012 data were not available, the 2012 cesarean delivery rate was imputed from other years. For the 22 countries for which no cesarean rate data were available, the rate was imputed from total health expenditure per capita, fertility rate, life expectancy, percent of urban population, and geographic region. EXPOSURES: Cesarean delivery rate. MAIN OUTCOMES AND MEASURES: The relationship between population-level cesarean delivery rate and maternal mortality ratios (maternal death from pregnancy related causes during pregnancy or up to 42 days postpartum per 100,000 live births) or neonatal mortality rates (neonatal mortality before age 28 days per 1000 live births).
RESULTS: The estimated number of cesarean deliveries in 2012 was 22.9 million (95% CI, 22.5 million to 23.2 million). At a country-level, cesarean delivery rate estimates up to 19.1 per 100 live births (95% CI, 16.3 to 21.9) and 19.4 per 100 live births (95% CI, 18.6 to 20.3) were inversely correlated with maternal mortality ratio (adjusted slope coefficient, -10.1; 95% CI, -16.8 to -3.4; P = .003) and neonatal mortality rate (adjusted slope coefficient, -0.8; 95% CI, -1.1 to -0.5; P < .001), respectively (adjusted for total health expenditure per capita, population, percent of urban population, fertility rate, and region). Higher cesarean delivery rates were not correlated with maternal or neonatal mortality at a country level. A sensitivity analysis including only 76 countries with the highest-quality cesarean delivery rate information had a similar result: cesarean delivery rates greater than 6.9 to 20.1 per 100 live births were inversely correlated with the maternal mortality ratio (slope coefficient, -21.3; 95% CI, -32.2 to -10.5, P < .001). Cesarean delivery rates of 12.6 to 24.0 per 100 live births were inversely correlated with neonatal mortality (slope coefficient, -1.4; 95% CI, -2.3 to -0.4; P = .004). CONCLUSIONS AND RELEVANCE: National cesarean delivery rates of up to approximately 19 per 100 live births were associated with lower maternal or neonatal mortality among WHO member states. Previously recommended national target rates for cesarean deliveries may be too low.

Entities:  

Mesh:

Year:  2015        PMID: 26624825     DOI: 10.1001/jama.2015.15553

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  144 in total

1.  Antenatal Management for Women with Inflammatory Bowel Disease: Experience from Our 'IBD MOM' Clinic.

Authors:  Ariella Bar-Gil Shitrit; Yael Cohen; Ori Hassin; Ami Ben Ya'acov; Rivkah Farkash; Benjamin Koslowsky; Yael Milgrom; Dan Meir Livovsky; Arnon Samueloff; Eran Goldin; Sorina Grisaru-Granovsky
Journal:  Dig Dis Sci       Date:  2018-04-06       Impact factor: 3.199

2.  Report on Advances for General Medicine in 2019: Neurosurgery, Urology, Gynecology and Obstetrics, and Internal Medicine.

Authors:  Hakan Doneray
Journal:  Eurasian J Med       Date:  2020-06

3.  Maternal Opioids Usage and Cesarean Delivery Rates: A Retrospective Cross-Sectional Analysis.

Authors:  Carolyn Knoll; Beri Massa-Buck; Dinan Abdelatif; Amr Madkour; Mohamed Mohamed
Journal:  Matern Child Health J       Date:  2021-05-24

4.  Electronic fetal monitoring, cerebral palsy, and caesarean section: assumptions versus evidence.

Authors:  Karin B Nelson; Thomas P Sartwelle; Dwight J Rouse
Journal:  BMJ       Date:  2016-12-01

5.  Elective cesarean delivery at term and the long-term risk for respiratory morbidity of the offspring.

Authors:  Yael Baumfeld; Asnat Walfisch; Tamar Wainstock; Idit Segal; Ruslan Sergienko; Daniella Landau; Eyal Sheiner
Journal:  Eur J Pediatr       Date:  2018-08-08       Impact factor: 3.183

Review 6.  High-quality health systems in the Sustainable Development Goals era: time for a revolution.

Authors:  Margaret E Kruk; Anna D Gage; Catherine Arsenault; Keely Jordan; Hannah H Leslie; Sanam Roder-DeWan; Olusoji Adeyi; Pierre Barker; Bernadette Daelmans; Svetlana V Doubova; Mike English; Ezequiel García-Elorrio; Frederico Guanais; Oye Gureje; Lisa R Hirschhorn; Lixin Jiang; Edward Kelley; Ephrem Tekle Lemango; Jerker Liljestrand; Address Malata; Tanya Marchant; Malebona Precious Matsoso; John G Meara; Manoj Mohanan; Youssoupha Ndiaye; Ole F Norheim; K Srinath Reddy; Alexander K Rowe; Joshua A Salomon; Gagan Thapa; Nana A Y Twum-Danso; Muhammad Pate
Journal:  Lancet Glob Health       Date:  2018-09-05       Impact factor: 26.763

Review 7.  Making cesarean delivery SAFE in low- and middle-income countries.

Authors:  Margo S Harrison; Robert L Goldenberg
Journal:  Semin Perinatol       Date:  2019-03-16       Impact factor: 3.300

Review 8.  Killer-cell immunoglobulin-like receptors on the cusp of modern immunogenetics.

Authors:  Francesco Colucci; James Traherne
Journal:  Immunology       Date:  2017-09-12       Impact factor: 7.397

9.  Understanding Recent Home-Birth Research: An Interview With Drs. Melissa Cheyney and Jonathan Snowden.

Authors:  Melissa Cheyney
Journal:  J Perinat Educ       Date:  2016

10.  Letter to the Editor: Author Response.

Authors:  Chris Vinden; Michael Ott
Journal:  Can J Surg       Date:  2016-04       Impact factor: 2.089

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.